DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal Consta (Risperidone) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (39)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 39   Next >>

Possible Risperdal Consta side effects in female

Reported by a physician from France on 2012-08-06

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Cerebrovascular Accident, Viith Nerve Paralysis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta

Other drugs received by patient: Tegretol



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a physician from Canada on 2012-08-01

Patient: male, weighing 90.0 kg (198.0 pounds)

Reactions: Surgery, Suicide Attempt, Multiple Fractures

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Celexa
    Dosage: every day before noon
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-11-01

Celexa
    Administration route: Oral
    End date: 2012-03-15

Invega Sustenna
    Dosage: 4/52
    End date: 2012-06-22

Invega Sustenna
    Start date: 2012-04-24

Invega Sustenna
    Start date: 2012-03-27

Invega Sustenna
    Dosage: initiated an day-8, after initiation dose
    Indication: Schizophrenia
    Start date: 2012-05-22

Olanzapine
    Dosage: every night
    Administration route: Oral
    Indication: Acute Psychosis

Olanzapine
    Dosage: every night at bed time x every 2 weeks
    Administration route: Oral
    End date: 2012-02-01

Olanzapine
    Dosage: every night x once every 2 weeks
    Administration route: Oral
    Start date: 2012-01-12

Risperdal Consta
    Start date: 2011-05-01

Risperdal Consta
    Start date: 2012-03-13

Risperdal Consta
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-15

Risperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-23

Patient: male

Reactions: Ischaemic Stroke, Psychiatric Decompensation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Loxapine HCL
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-12-02
    End date: 2010-12-08

Risperdal
    Administration route: Oral
    Start date: 2010-12-02
    End date: 2010-12-08

Risperdal
    Administration route: Oral
    Start date: 2010-11-23

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-12-16

Risperdal Consta
    Indication: Persecutory Delusion
    Start date: 2010-12-03
    End date: 2010-12-03

Tercian
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-07-09
    End date: 2010-12-02

Zyprexa
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-07-09
    End date: 2010-11-23

Other drugs received by patient: Imovane; Lepticur; Lepticur; Polyethylene Glycol; Escitalopram



Possible Risperdal Consta side effects in 35 year old male

Reported by a physician from Australia on 2012-07-20

Patient: 35 year old male

Reactions: Akathisia, Therapeutic Response Decreased, Incorrect Dose Administered, Cardiomyopathy, Delirium

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Clozapine
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-01



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in 41 year old male

Reported by a physician from Germany on 2012-06-18

Patient: 41 year old male

Reactions: Pulmonary Embolism

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2012-03-01

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-02-29

Risperdal Consta
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-12
    End date: 2012-04-12

Risperdal Consta
    Start date: 2012-03-29
    End date: 2012-03-29

Other drugs received by patient: Lorazepam; Bisoprolol Fumarate; Remergil; Remergil; Lorazepam; Remergil; Remergil; Venlafaxine Hydrochloride; Remergil; Lorazepam; Lorazepam; Lorazepam; Venlafaxine Hydrochloride



Possible Risperdal Consta side effects in female

Reported by a physician from Canada on 2012-06-11

Patient: female, weighing 63.5 kg (139.7 pounds)

Reactions: Inappropriate Schedule of Drug Administration, Hodgkin's Disease

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Concerta
    Dosage: 50 (unit unspecified)
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2011-09-01

Risperdal Consta
    Indication: Psychotic Disorder
    Start date: 2011-09-01

Other drugs received by patient: Clonazepam



Possible Risperdal Consta side effects in female

Reported by a physician from Canada on 2012-06-05

Patient: female, weighing 63.5 kg (139.7 pounds)

Reactions: Inappropriate Schedule of Drug Administration, Hodgkin's Disease

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Concerta
    Dosage: 50 (unit unspecified)
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2011-09-01

Risperdal Consta
    Indication: Psychotic Disorder

Other drugs received by patient: Clonazepam



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-04

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Sepsis, Malnutrition, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal Consta side effects in female

Reported by a physician from China on 2012-05-18

Patient: female

Reactions: Ventricular Tachycardia, Atrial Fibrillation, Arrhythmia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-11-01
    End date: 2011-01-01

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2010-11-18
    End date: 2010-12-18

Risperidone
    Administration route: Oral

Risperidone
    Dosage: 2~3ml/d
    Administration route: Oral

Risperidone
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-11-18
    End date: 2011-02-18



Possible Risperdal Consta side effects in 49 year old male

Reported by a physician from Japan on 2012-05-11

Patient: 49 year old male, weighing 45.0 kg (99.0 pounds)

Reactions: Dysphagia, Cyanosis, Hypoglycaemia, Sepsis, Coma, Parkinsonism

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2008-06-08
    End date: 2010-12-07

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2010-12-21
    End date: 2010-12-21

Other drugs received by patient: Alosenn; Levomepromazine Maleate; Magnesium Oxide; Anginal



Possible Risperdal Consta side effects in female

Reported by a physician from China on 2012-05-02

Patient: female

Reactions: Ventricular Tachycardia, Atrial Fibrillation, Arrhythmia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-11-01
    End date: 2011-01-01

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2010-11-18
    End date: 2010-12-18

Risperidone
    Dosage: 2~3ml/d
    Administration route: Oral

Risperidone
    Administration route: Oral

Risperidone
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2010-11-18
    End date: 2011-02-18



Possible Risperdal Consta side effects in female

Reported by a health professional (non-physician/pharmacist) from NEW Zealand on 2012-04-27

Patient: female

Reactions: Road Traffic Accident, Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in male

Reported by a pharmacist from United Kingdom on 2012-03-27

Patient: male

Reactions: Respiratory Failure, Pancreatitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-23

Patient: 36 year old female

Reactions: Pulmonary Embolism

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 49 year old male

Reported by a physician from Japan on 2012-03-07

Patient: 49 year old male, weighing 45.0 kg (99.0 pounds)

Reactions: Dysphagia, Sepsis, Hypoglycaemia, Coma

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Schizophrenia
    Start date: 2010-12-21
    End date: 2010-12-21

Risperdal Consta
    Start date: 2008-06-08
    End date: 2010-12-07

Other drugs received by patient: Anginal; Alosenn; Magnesium Oxide; Levomepromazine Maleate



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-06

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal Consta side effects in female

Reported by a pharmacist from Netherlands on 2012-02-29

Patient: female

Reactions: Thrombosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



Possible Risperdal Consta side effects in female

Reported by a pharmacist from Netherlands on 2012-02-23

Patient: female

Reactions: Thrombosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 48 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-17

Patient: 48 year old male

Reactions: Pulmonary Embolism, Toxicity To Various Agents, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Havlane (Loprazolam Mesilate)
    Dosage: ;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-02
    End date: 2011-06-02

Lepticur (Tropatepine Hydrochloride)
    Dosage: 10 mg; bid; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01
    End date: 2011-06-01

Mirtazapine
    Dosage: 15 mg;bid;po; 15 mg;qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-07

Risperdal
    Dosage: 2 mg;qpm;po;2 mg;qd;po; 4 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-01

Risperdal
    Dosage: 2 mg;qpm;po;2 mg;qd;po; 4 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-07
    End date: 2011-06-10

Risperdal
    Dosage: 2 mg;qpm;po;2 mg;qd;po; 4 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-10
    End date: 2011-06-29

Risperdal Consta
    Dosage: 3.3333 mg;qd;im
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-15
    End date: 2011-06-29

Sulfarlem (Anethole Trithione)
    Dosage: 150 mg; qd; po
    Administration route: Oral
    Indication: Aptyalism
    Start date: 2011-05-01

Trimeprazine Tartrate
    Dosage: 10 gtt;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01
    End date: 2011-06-01



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-13

Patient: male

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Havlane
    Dosage: one box
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 2011-06-02
    End date: 2011-06-02

Lepticur
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 2011-05-01
    End date: 2011-06-01

Mirtazapine
    Administration route: Oral
    Indication: Ill-Defined Disorder

Risperdal
    Administration route: Oral
    Start date: 2011-04-01
    End date: 2011-06-10

Risperdal
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 2011-06-10
    End date: 2011-06-29

Risperdal Consta
    Indication: Ill-Defined Disorder
    Start date: 2011-06-15
    End date: 2011-06-29

Sulfarlem
    Administration route: Oral
    Indication: Aptyalism
    Start date: 2011-05-01

Trimeprazine Tartrate
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 2011-05-01
    End date: 2011-06-01



Possible Risperdal Consta side effects in female

Reported by a physician from Germany on 2012-01-20

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Basal Ganglia Infarction, Drug Interaction, Hemiparesis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2011-10-12
    End date: 2011-10-12

Risperdal Consta
    Indication: Psychotic Disorder
    End date: 2011-09-14

Risperdal Consta
    Start date: 2011-09-28
    End date: 2011-09-28

Other drugs received by patient possibly interacting with the suspect drug:
Zopiclon
    Administration route: Oral
    Indication: Sleep Disorder

Other drugs received by patient: Seroquel; Mirtazapine; Mirtazapine



Possible Risperdal Consta side effects in male

Reported by a physician from Japan on 2012-01-05

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Shock Haemorrhagic, Schizophrenia, Emotional Disorder, Treatment Noncompliance, Gastric Ulcer

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Start date: 2010-07-07
    End date: 2010-10-19

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2010-10-20
    End date: 2011-05-30

Other drugs received by patient: Depakene; Lonasen; Rohypnol; Senevacul; Lonasen; Magnesium Sulfate



Possible Risperdal Consta side effects in 52 year old male

Reported by a physician from Japan on 2011-12-23

Patient: 52 year old male

Reactions: Hyponatraemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 18 year old male

Reported by a pharmacist from United States on 2011-12-20

Patient: 18 year old male, weighing 105.9 kg (233.0 pounds)

Reactions: Neuroleptic Malignant Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in male

Reported by a physician from France on 2011-12-09

Patient: male

Reactions: Psychotic Disorder, Pulmonary Embolism

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Administration route: Oral
    Indication: Psychotic Disorder

Imovane
    Administration route: Oral
    Indication: Insomnia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-09-08



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-07

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizophrenia

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-06-18



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017